tm logo
KAYAK
SEARCHED

on 29 Oct 2024

Last Applicant/ Owned by

NEUROCRINE BIOSCIENCES INC.

12780 El Camino RealSan Diego, CA 92130

US

Serial Number

2101047 filed on 20th Apr 2021

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

KAYAK

Trademark usage description

pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research f Read More

Classification Information


Class [042]
Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders


Classification kind code

11

Class [044]
Providing medical information; providing research information to patients and practitioners as to the results of clinical trials; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders; providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2101047

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 29th Oct 2024
Search Recorded
Submitted for opposition 20
on 29th Oct 2024
Examiner's First Report
Submitted for opposition 287
on 30th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 20th Apr 2021
Filed
Submitted for opposition 1
on 20th Apr 2021
Created
Submitted for opposition 31
on 20th Apr 2021
Formalized